Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
View ORCID ProfileMinh-Phuong Huynh-Le, Chun Chieh Fan, Roshan Karunamuni, Wesley K Thompson, Maria Elena Martinez, Rosalind A Eeles, Zsofia Kote-Jarai, Kenneth Muir, UKGPCS collaborators, Johanna Schleutker, Nora Pashayan, Jyotsna Batra, APCB (Australian Prostate Cancer BioResource), Henrik Grönberg, David E Neal, Jenny L Donovan, Freddie C Hamdy, Richard M Martin, Sune F Nielsen, Børge G Nordestgaard, Fredrik Wiklund, Catherine M Tangen, Graham G Giles, Alicja Wolk, Demetrius Albanes, Ruth C Travis, William J Blot, View ORCID ProfileWei Zheng, Maureen Sanderson, Janet L Stanford, Lorelei A Mucci, Catharine M L West, Adam S Kibel, Olivier Cussenot, Sonja I Berndt, Stella Koutros, View ORCID ProfileKarina Dalsgaard Sørensen, Cezary Cybulski, Eli Marie Grindedal, Florence Menegaux, Kay-Tee Khaw, Jong Y Park, Sue A Ingles, Christiane Maier, Robert J Hamilton, Stephen N Thibodeau, Barry S Rosenstein, Yong-Jie Lu, Stephen Watya, Ana Vega, NC-LA PCaP Investigators, The IMPACT Study Steering Committee and Collaborators, Manolis Kogevinas, Kathryn L Penney, Chad Huff, Manuel R Teixeira, Luc Multigner, Robin J Leach, Lisa Cannon-Albright, Hermann Brenner, Esther M John, Radka Kaneva, Christopher J Logothetis, Susan L Neuhausen, Kim De Ruyck, Hardev Pandha, Azad Razack, Lisa F Newcomb, Canary PASS Investigators, Jay Fowke, Marija Gamulin, Nawaid Usmani, Frank Claessens, Manuela Gago-Dominguez, Paul A Townsend, William S Bush, Shiv Srivastava, Monique J Roobol, Marie-Élise Parent, Jennifer J Hu, The Profile Study Steering Committee, Ian G Mills, Ole A Andreassen, Anders M Dale, Tyler M Seibert, The PRACTICAL Consortium
doi: https://doi.org/10.1101/19012237
Minh-Phuong Huynh-Le
1Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA
2Center for Multimodal Imaging and Genetics, University of California, San Diego, La Jolla, CA, USA
Chun Chieh Fan
2Center for Multimodal Imaging and Genetics, University of California, San Diego, La Jolla, CA, USA
Roshan Karunamuni
1Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA
2Center for Multimodal Imaging and Genetics, University of California, San Diego, La Jolla, CA, USA
Wesley K Thompson
3Division of Biostatistics and Halicioğlu Data Science Institute, University of California San Diego
4Department of Family Medicine and Public Health, University of California San Diego
Maria Elena Martinez
5University of California San Diego, Moores Cancer Center, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA 92093-0012, USA
Rosalind A Eeles
6The Institute of Cancer Research, London, SM2 5NG, UK
7Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK
Zsofia Kote-Jarai
6The Institute of Cancer Research, London, SM2 5NG, UK
Kenneth Muir
8Division of Population Health, Health Services Research and Primary Care, University of Manchester, Oxford Road, Manchester, M13 9PL, UK
9Warwick Medical School, University of Warwick, Coventry, UK
10
Johanna Schleutker
11Institute of Biomedicine, Kiinamyllynkatu 10, FI-20014 University of Turku, Finland
12Department of Medical Genetics, Genomics, Laboratory Division, Turku University Hospital, PO Box 52, 20521 Turku, Finland
Nora Pashayan
13University College London, Department of Applied Health Research, London, UK
14Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, CB1 8RN, UK
15Department of Applied Health Research, University College London, London, WC1E 7HB, UK
Jyotsna Batra
16Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane QLD 4059, Australia
17Translational Research Institute, Brisbane, Queensland 4102, Australia
18Australian Prostate Cancer Research Centre-Qld, Queensland University of Technology, Brisbane; Prostate Cancer Research Program, Monash University, Melbourne; Dame Roma Mitchell Cancer Centre, University of Adelaide, Adelaide; Chris O’Brien Lifehouse and The Kinghorn Cancer Centre, Sydney, Australia
19Translational Research Institute, Brisbane, Queensland, Australia
Henrik Grönberg
20Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden
David E Neal
21Nuffield Department of Surgical Sciences, University of Oxford, Room 6603, Level 6, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK
22University of Cambridge, Department of Oncology, Box 279, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 0QQ, UK
23Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge UK
Jenny L Donovan
24Population Health Sciences, Bristol Medical School, University of Bristol, BS8 2PS, UK
Freddie C Hamdy
25Nuffield Department of Surgical Sciences, University of Oxford, Oxford, OX1 2JD, UK
26Faculty of Medical Science, University of Oxford, John Radcliffe Hospital, Oxford, UK
Richard M Martin
24Population Health Sciences, Bristol Medical School, University of Bristol, BS8 2PS, UK
27National Institute for Health Research (NIHR) Biomedical Research Centre, University of Bristol, Bristol, BS8 1TH, UK
28Medical Research Council (MRC) Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK
Sune F Nielsen
29Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark
30Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200 Copenhagen, Denmark
Børge G Nordestgaard
31Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark
32Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200 Copenhagen, Denmark
Fredrik Wiklund
33Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77 Stockholm, Sweden
Catherine M Tangen
34SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Graham G Giles
35Cancer Epidemiology Division, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC 3004, Australia
36Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia
37Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria 3168, Australia
Alicja Wolk
38Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden
39Department of Surgical Sciences, Uppsala University, 75185 Uppsala, Sweden
Demetrius Albanes
40Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA
Ruth C Travis
41Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK
William J Blot
42Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600, Nashville, TN 37232 USA
43International Epidemiology Institute, Rockville, MD 20850, USA
Wei Zheng
44Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 800, Nashville, TN 37232 USA
Maureen Sanderson
45Department of Family and Community Medicine, Meharry Medical College, 1005 Dr. DB Todd Jr. Blvd., Nashville, TN 37208 USA
Janet L Stanford
46Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109-1024, USA
47Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington 98195, USA
Lorelei A Mucci
48Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA
Catharine M L West
49Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Radiotherapy Related Research, The Christie Hospital NHS Foundation Trust, Manchester, M13 9PL UK
Adam S Kibel
50Division of Urologic Surgery, Brigham and Womens Hospital, 75 Francis Street, Boston, MA 02115, USA
Olivier Cussenot
51Sorbonne Universite, GRC n°5, AP-HP, Tenon Hospital, 4 rue de la Chine, F-75020 Paris, France
52CeRePP, Tenon Hospital, Paris, France
Sonja I Berndt
53Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA
Stella Koutros
53Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA
Karina Dalsgaard Sørensen
54Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensen Boulevard 99, 8200 Aarhus N, Denmark
55Department of Clinical Medicine, Aarhus University, DK-8200 Aarhus N
Cezary Cybulski
56International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
Eli Marie Grindedal
57Department of Medical Genetics, Oslo University Hospital, 0424 Oslo, Norway
Florence Menegaux
58Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, 94807 Villejuif Cédex, France
59Paris-Sud University, UMRS 1018, 94807 Villejuif Cedex, France
Kay-Tee Khaw
60Clinical Gerontology Unit, University of Cambridge, Cambridge, CB2 2QQ, UK
Jong Y Park
61Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA
Sue A Ingles
62Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California, USA
Christiane Maier
63Humangenetik Tuebingen, Paul-Ehrlich-Str 23, D-72076 Tuebingen, Germany
Robert J Hamilton
64Dept. of Surgical Oncology, Princess Margaret Cancer Centre, Toronto ON M5G 2M9, Canada
65Dept. of Surgery (Urology), University of Toronto, Canada
Stephen N Thibodeau
66Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
Barry S Rosenstein
67Department of Radiation Oncology and Department of Genetics and Genomic Sciences, Box 1236, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA
68Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029-5674, USA
Yong-Jie Lu
69Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK
Stephen Watya
70Uro Care, Kampala, Uganda
Ana Vega
71Fundación Pública Galega Medicina Xenómica, Santiago De Compostela, 15706, Spain
72Instituto de InvestigaciónSanitaria de Santiago de Compostela, Santiago De Compostela, 15706, Spain
73Centro de Investigaciónen Red de Enfermedades Raras (CIBERER), Spain
74Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
75Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, CB 7295, Chapel Hill, NC 27599, USA
76Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
77
Manolis Kogevinas
78ISGlobal, Barcelona, Spain
79IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
80Universitat Pompeu Fabra (UPF), Barcelona, Spain
Kathryn L Penney
81Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA 02184, USA
Chad Huff
82The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA
Manuel R Teixeira
83Department of Genetics, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal
84Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal
Luc Multigner
85Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France
Robin J Leach
86Department of Urology, Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio Texas
Lisa Cannon-Albright
87Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA
88George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah 84148, USA
Hermann Brenner
89Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany
90German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany
91Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460 69120 Heidelberg, Germany
Esther M John
92Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 780 Welch Road, CJ250C, CA 94304-5769
Radka Kaneva
93Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, 2 Zdrave Str., 1431 Sofia, Bulgaria
Christopher J Logothetis
94The University of Texas M. D. Anderson Cancer Center, Department of Genitourinary Medical Oncology, 1515 Holcombe Blvd., Houston, TX 77030, USA
Susan L Neuhausen
95Department of Population Sciences, Beckman Research Institute of the City of Hope, 1500 East Duarte Road, Duarte, CA 91010, 626-256-HOPE (4673)
Kim De Ruyck
96Ghent University, Faculty of Medicine and Health Sciences, Basic Medical Sciences, Proeftuinstraat 86, B-9000 Gent
Hardev Pandha
97The University of Surrey, Guildford, Surrey, GU2 7XH
Azad Razack
98Department of Surgery, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
Lisa F Newcomb
46Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109-1024, USA
99Department of Urology, University of Washington, 1959 NE Pacific Street, Box 356510, Seattle, WA 98195, USA
46Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109-1024, USA
99Department of Urology, University of Washington, 1959 NE Pacific Street, Box 356510, Seattle, WA 98195, USA
Jay Fowke
100Department of Medicine and Urologic Surgery, Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville, TN 37232, USA
Marija Gamulin
101Division of Medical Oncology, Urogenital Unit, Department of Oncology, University Hospital Centre Zagreb, University of Zagreb, School of Medicine, 10 000 Zagreb, Croatia
Nawaid Usmani
102Department of Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, Alberta, Canada T6G 1Z2
103Division of Radiation Oncology, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada T6G 1Z2
Frank Claessens
104Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, BE-3000, Belgium
Manuela Gago-Dominguez
105Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, 15706, Santiago de Compostela, Spain
106University of California San Diego, Moores Cancer Center, La Jolla, CA 92037, USA
Paul A Townsend
107Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, M13 9WL
William S Bush
108Case Western Reserve University, Department of Population and Quantitative Health Sciences, Cleveland Institute for Computational Biology, 2103 Cornell Road, Wolstein Research Building, Suite 2527, Cleveland, OH, 44106 USA
Shiv Srivastava
109Uniformed Services University, 4301 Jones Bridge Rd, Bethesda, MD 20814, USA
110Center for Prostate Disease Research, 1530 East Jefferson Street, Rockville, MD 20852, USA
Monique J Roobol
111Department of Clinical Chemistry, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
Marie-Élise Parent
112Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique, 531 Boul. des Prairies, Laval, QC, Canada H7V 1B7
113Department of Social and Preventive Medicine, School of Public Health, University of Montreal, Montreal, QC, Canada
Jennifer J Hu
114The University of Miami School of Medicine, Sylvester Comprehensive Cancer Center, 1120 NW 14th Street, CRB 1511, Miami, Florida 33136, USA
115
Ian G Mills
116Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK
Ole A Andreassen
117NORMENT, KG Jebsen Centre, Oslo University Hospital and University of Oslo, Oslo, Norway
Anders M Dale
118Department of Radiology, University of California San Diego, La Jolla, CA, USA
Tyler M Seibert
1Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA
2Center for Multimodal Imaging and Genetics, University of California, San Diego, La Jolla, CA, USA
119Department of Bioengineering, University of California San Diego, La Jolla, CA, USA
Article usage
Posted May 08, 2020.
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
Minh-Phuong Huynh-Le, Chun Chieh Fan, Roshan Karunamuni, Wesley K Thompson, Maria Elena Martinez, Rosalind A Eeles, Zsofia Kote-Jarai, Kenneth Muir, UKGPCS collaborators, Johanna Schleutker, Nora Pashayan, Jyotsna Batra, APCB (Australian Prostate Cancer BioResource), Henrik Grönberg, David E Neal, Jenny L Donovan, Freddie C Hamdy, Richard M Martin, Sune F Nielsen, Børge G Nordestgaard, Fredrik Wiklund, Catherine M Tangen, Graham G Giles, Alicja Wolk, Demetrius Albanes, Ruth C Travis, William J Blot, Wei Zheng, Maureen Sanderson, Janet L Stanford, Lorelei A Mucci, Catharine M L West, Adam S Kibel, Olivier Cussenot, Sonja I Berndt, Stella Koutros, Karina Dalsgaard Sørensen, Cezary Cybulski, Eli Marie Grindedal, Florence Menegaux, Kay-Tee Khaw, Jong Y Park, Sue A Ingles, Christiane Maier, Robert J Hamilton, Stephen N Thibodeau, Barry S Rosenstein, Yong-Jie Lu, Stephen Watya, Ana Vega, NC-LA PCaP Investigators, The IMPACT Study Steering Committee and Collaborators, Manolis Kogevinas, Kathryn L Penney, Chad Huff, Manuel R Teixeira, Luc Multigner, Robin J Leach, Lisa Cannon-Albright, Hermann Brenner, Esther M John, Radka Kaneva, Christopher J Logothetis, Susan L Neuhausen, Kim De Ruyck, Hardev Pandha, Azad Razack, Lisa F Newcomb, Canary PASS Investigators, Jay Fowke, Marija Gamulin, Nawaid Usmani, Frank Claessens, Manuela Gago-Dominguez, Paul A Townsend, William S Bush, Shiv Srivastava, Monique J Roobol, Marie-Élise Parent, Jennifer J Hu, The Profile Study Steering Committee, Ian G Mills, Ole A Andreassen, Anders M Dale, Tyler M Seibert, The PRACTICAL Consortium
medRxiv 19012237; doi: https://doi.org/10.1101/19012237
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
Minh-Phuong Huynh-Le, Chun Chieh Fan, Roshan Karunamuni, Wesley K Thompson, Maria Elena Martinez, Rosalind A Eeles, Zsofia Kote-Jarai, Kenneth Muir, UKGPCS collaborators, Johanna Schleutker, Nora Pashayan, Jyotsna Batra, APCB (Australian Prostate Cancer BioResource), Henrik Grönberg, David E Neal, Jenny L Donovan, Freddie C Hamdy, Richard M Martin, Sune F Nielsen, Børge G Nordestgaard, Fredrik Wiklund, Catherine M Tangen, Graham G Giles, Alicja Wolk, Demetrius Albanes, Ruth C Travis, William J Blot, Wei Zheng, Maureen Sanderson, Janet L Stanford, Lorelei A Mucci, Catharine M L West, Adam S Kibel, Olivier Cussenot, Sonja I Berndt, Stella Koutros, Karina Dalsgaard Sørensen, Cezary Cybulski, Eli Marie Grindedal, Florence Menegaux, Kay-Tee Khaw, Jong Y Park, Sue A Ingles, Christiane Maier, Robert J Hamilton, Stephen N Thibodeau, Barry S Rosenstein, Yong-Jie Lu, Stephen Watya, Ana Vega, NC-LA PCaP Investigators, The IMPACT Study Steering Committee and Collaborators, Manolis Kogevinas, Kathryn L Penney, Chad Huff, Manuel R Teixeira, Luc Multigner, Robin J Leach, Lisa Cannon-Albright, Hermann Brenner, Esther M John, Radka Kaneva, Christopher J Logothetis, Susan L Neuhausen, Kim De Ruyck, Hardev Pandha, Azad Razack, Lisa F Newcomb, Canary PASS Investigators, Jay Fowke, Marija Gamulin, Nawaid Usmani, Frank Claessens, Manuela Gago-Dominguez, Paul A Townsend, William S Bush, Shiv Srivastava, Monique J Roobol, Marie-Élise Parent, Jennifer J Hu, The Profile Study Steering Committee, Ian G Mills, Ole A Andreassen, Anders M Dale, Tyler M Seibert, The PRACTICAL Consortium
medRxiv 19012237; doi: https://doi.org/10.1101/19012237
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)